emyria is focused on data-backed drug development. emyria’s treatments and drug development programs address unmet needs and are unique in that they are informed by Real World Evidence (RWE) they create with patients across their clinical service. Patients are part of the clinical research journey.
CT:IQ is thrilled to welcome emyria to the Steering Committee.
